We use cookies to provide you with the best of services and customized features. By continuing to browse this website, you give your informed consent to our Cookie Policy.
An Izmir Biomedicine and Genome Center team, led by Prof. Dr. Hulya Ayar Kayali, has developed an innovative ovarian cancer treatment with minimal side effects
